T reg lymphocytes in autoimmune uveitis

Ocular Immunology and Inflammation

Volumn 20, Issue 4, 2012, Pages 255-261

  Ruggieri, Simona ^a   Frassanito, Maria Antonia ^a   Dammacco, Rosanna ^a   Guerriero, Silvana ^a  

^a UNIVERSITY OF BARI   (Italy)

Author keywords

Cytotoxic T lymphocyte associated antigen (CTLA) 4; Immunomodulatory therapy; Interleukin 2 receptor chain (CD25); Noninfectious uveitis; Standardization of uveitis nomenclature; T regulatory cells

Indexed keywords

AZATHIOPRINE; CD4 ANTIGEN; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; INTERLEUKIN 2 RECEPTOR ALPHA; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; TRANSCRIPTION FACTOR FOXP3; CTLA4 PROTEIN, HUMAN; FORKHEAD TRANSCRIPTION FACTOR; FOXP3 PROTEIN, HUMAN; IMMUNOSUPPRESSIVE AGENT;

ADOLESCENT; ADULT; AGED; ANTIGEN EXPRESSION; ANTIGEN PRESENTING CELL; ARTICLE; AUTOIMMUNE UVEITIS; CD4+ CD25+ T LYMPHOCYTE; CELL ISOLATION; CELL POPULATION; CLINICAL FEATURE; CONTROLLED STUDY; DRUG DOSE REDUCTION; FEMALE; GASTROINTESTINAL TOXICITY; HUMAN; HUMAN CELL; IMMUNOMODULATION; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; PERIPHERAL BLOOD MONONUCLEAR CELL; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; REMISSION; T LYMPHOCYTE ACTIVATION; TREATMENT OUTCOME; AUTOIMMUNE DISEASE; BIOSYNTHESIS; DRUG EFFECT; IMMUNOLOGY; METABOLISM; MIDDLE AGED; UVEITIS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; AUTOIMMUNE DISEASES; CTLA-4 ANTIGEN; FEMALE; FORKHEAD TRANSCRIPTION FACTORS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; MIDDLE AGED; T-LYMPHOCYTES, REGULATORY; UVEITIS; YOUNG ADULT;

EID: 84864367928     PISSN: 09273948     EISSN: 17445078     Source Type: Journal    
DOI: 10.3109/09273948.2012.681830     Document Type: Article

References (31)

1. Caspi RR. Immune mechanism in uveitis. Springer Semin Immunopathol. 1999;21:113-124.
2. Redpath S, Ghazal P, Gascoigne NR. Hijacking: Exploration of IL-10 by intracellular pathogens. Trend Microbiol. 2001;9:86-92. (Pubitemid 32155327)
3. Reed SG. TGF-ǎ in infections and infectious diseases. Microbes infect. 1999;1:1313-1325.
4. Maggi E, Cosmi L, Liotta F, Romagnani P, Romagnani S, Annunziato F. Thymic regulatory T cells. Autoimmun Rev. 2005;4:579-586. (Pubitemid 41415773)
5. Bluestone JA, . Tang Q. How do CD4+CD25+ regulatory T cells control autoimmunity? Curr Op Immunol. 2005; 7:638-642. (Pubitemid 41506909)
6. Seddon B, Mason D. Peripheral autoantigen induces regulatory T cells that prevent autoimmunity. J Exp Med. 1999; 189:877-882.
7. Sakagushi S. Naturally arising FoxP3-expressing CD25+CD4+ regulatory T cells in immunological tolerance to self and non self. Nat Immunol. 2005;6:345-352.
8. Fontenot JP, Ruensky AY. A well adapted regulatory contrivance: Regulatory T cell development and forkhead family transcription factor FoxP3. Nat Immunol. 2005;6:331-337.
9. Bennet CL, Christie J, Ramsdell F, et al. The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3. Nat Genet. 2001;27: 20-21. (Pubitemid 32044513)
10. Brunkow ME, Jeffery EW, Hjerrild KA, et al. Disruption of a new forkhead/winged-helix protein, scurfin, results in the fatal lymphoproliferative disorder of the scurfy mouse. Nat Genet. 2001;27:68-73. (Pubitemid 32044521)
11. Thompson CB, Allison JP. The emerging role of CTLA-4 as an immune attenuator. Immunity. 1997;7:445-450. (Pubitemid 27508696)
12. Bluestone JA. Is CTLA-4 a master switch for peripheral T cell tolerance? J Immunol. 1997;158:1989-1993.
13. Thornton AM, Shevach EM. CD4+CD25+ Immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting Interleukin 2 production. J Exp Med. 1998;188:287-296. (Pubitemid 28357757)
14. Jabs DA, Nussenblatt RB, Rosenbaum JT; Standardization of Uveitis Nomenclature (SUN) Working Group. Standardization of uveitis nomenclature for reporting clinical data: Results of the First International Workshop. Am J Ophthalmol. 2005 Sep;140(3):509-516. (Pubitemid 41224845)
15. Khairallah M. Are the Standardization of the Uveitis Nomenclature (SUN) Working Group criteria for codifying the site of inflammation appropriate for all uveitis problems? Limitations of the SUN Working Group classification. Ocul Immunol Inflamm. 2010 Jan;18(1):2-4.
16. Chen L. Yang P, Zhou H, et al. Decreased frequency and diminished function of CD4+ CD25high regulatory T cells associated with active uveitis in Vogt-Koyanagi-Harada syndrome. Invest Ophthalm Vis Sci. 2008;49(8):3475-3482.
17. Hamazaoui K, Hamazaoui A, Houman H. CD4+CD25+ regulatory T cells in patients with Behcet's disease. Clin Exp Rheumatol. 2006;24(5)(suppl 42):571-578.
18. Yeh S, Li Z, Forooghian F, et al. CD4+ FoxP3+ T-regulatory cells in noninfectious uveitis. Arch Ophthalmol. 2009 Apr;127(4):407-413.
19. Nanke Y, Kotake S, Goto M, Ujihara H, Matsubara M, Kamatani N. Decreased percentages of regulatory T cells in peripheral blood of patients with Behcet's disease before ocular attack: A possible predictive marker of ocular attack. Mod Rheumatol. 2008;18(4):354-358.
20. Gavin MA, Torgerson TR, Houston E, et al. Single-cell analysis of normal and FoxP3-mutant human T cells: FoxP3 expression without regulatory T cell development. Proc Natl Acad Sci U S A. 2006;103:6659-6664.
21. Roncador G, Brown PJ, Maestre L, et al. Analysis of FoxP3 protein expression in human CD4(+)CD25(+) regulatory T cells at the single-cell level. Eur J Immunol. 2005;35:1681-1691. (Pubitemid 40862316)
22. Sakaguchi S, Sakaguchi N, Asano M, Itoh M, Toda M. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25): breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J Immunol. 1995 Aug 1;155(3):1151-1164.
23. Takahashi T, Kuniyasu Y, Toda M, et al. Immunologic selftolerance maintained by CD25+CD4+ naturally anergic and suppressive T cells: Induction of autoimmune disease by breaking their anergic/suppressive state. Int Immunol. 1998 Dec;10(12):1969-1980. (Pubitemid 28566059)
24. Thornton AM, Shevach EM. Suppressor effector function of CD4+CD25+ immunoregulatory T cells is antigen nonspecific. J Immunol. 2000;164:83-190.
25. Roncarolo AM, Bacchetta R, Bordignon C, Narula S, Levings MK. Type 1 T regulatory cells. Immunol Rev. 2001;182:68-79. (Pubitemid 33070208)
26. Costantino CM, Baecher-Allan CM, Hafler DA. Human regulatory T cells and autoimmunity. Eur J Immunol. 2008;38(4):921-924.
27. Valencia X, Lipsky PE. CD4+CD25+FoxP3+ regulatory T cells in autoimmune diseases. Nat Clin Pract Rheumatol. 2007;3(11):619-626.
28. Shevach EM, DiPaolo RA, Andersson J, Zhao DM, Stephens GL, Thornton AM. The lifestyle of naturally occurring CD4+CD25+FoxP3+ regulatory T cells. Immunol Rev. 2006; 212:60-73. (Pubitemid 44116700)
29. Keino H, Takeuchi M, Usui Y, et al. Supplementation of CD4+CD25+ regulatory T cells suppresses experimental autoimmune uveoretinitis. Br J Ophthalmol. 2007;91(1):105-110. (Pubitemid 46094020)
30. Asano M, Toda M, Sakaguchi N, Sakaguchi S. Autoimmune disease as a consequence of developmental abnormality of a T cell subpopulation. J Exp Med. 1996 Aug 1;184(2):387-396. (Pubitemid 26324092)
31. Itoh M, Takahashi T, Sakaguchi N, et al. Thymus and autoimmunity: Production of CD25+CD4+ naturally anergic and suppressive T cells as a key function of the thymus in maintaining immunologic self-tolerance. J Immunol. 1999 May 1; 162(9):5317-5326. (Pubitemid 29307138)